Clinical Trial Update: A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation trial of the investigational drug ZG006 in patients with small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• ZG006

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Small Cell Lung Cancer | Phase 1 | Status: RECRUITING